Pharmaceutically active compositions containing adriamycin and d

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424180, 536 17A, A61K 31705, C07H 1524

Patent

active

042632790

ABSTRACT:
Novel pharmaceutically active compositions of matter comprise in combination a low-molecular-weight anti-cancer drug chemically linked to antibodies selective or specific to tumor antigens. The preferred linkage is via covalent bonds, whether directly or via a linking agent. A method of treatment of mammals afflicted with malignant growth comprises administering a pharmaceutical composition of matter defined above.

REFERENCES:
patent: 3100203 (1963-08-01), Borchert
patent: 3794635 (1974-02-01), Evans
patent: 3803124 (1974-04-01), Arcamone et al.
patent: 3957755 (1976-05-01), Jolles
patent: 4093607 (1978-06-01), Sela et al.
O'Bryan et al., "Cancer," vol. 32, No. 1, pp. 1-8, Jul. 1973.
Frei, "Cancer," vol. 30, No. 6, pp. 1656-1661, Dec. 1972.
Johnson et al., "Cancer Treatment Reviews," pp. 1-31, 1975.
Levy et al., "Cancer Research," vol. 35, pp. 1182-1185, 1975.
Hurwitz et al., "Cancer Res.," vol. 35, pp. 1175-1181, 1975.
Hurwitz et al., "Cancer, Europ. J.," vol. 14, pp. 1213-1220, 1978.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutically active compositions containing adriamycin and d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically active compositions containing adriamycin and d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active compositions containing adriamycin and d will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-557631

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.